Lanean...

Advances in Liver Cancer Antibody Therapies: A Focus on Glypican-3 and Mesothelin

Liver cancer is one of the most common malignancies worldwide. Hepatocellular carcinoma (HCC) and cholangiocarcinoma (CCA) are the two most common primary liver cancers, yet there have been no significant advances in effective therapeutics. There is an urgent need to identify molecular targets for t...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Egile nagusia: Ho, Mitchell
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: 2011
Gaiak:
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC3198870/
https://ncbi.nlm.nih.gov/pubmed/21942912
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2165/11595360-000000000-00000
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!